Kyle Moran Wave Life Sciences Ltd. (WVE) insider trading activity

Kyle Moran is Chief Financial Officer of Wave Life Sciences Ltd.. Currently has a direct ownership of 90,365 shares of WVE, which is worth approximately $624,422. The most recent transaction as insider was on Dec 09, 2025, when has been sold 50,036 shares (Ordinary Shares) at a price of $20.14 per share, resulting in proceeds of $1,007,725. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.4K

1.29% 3M change

101.81% 12M change

Total Value Held $624,422

Kyle Moran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2025	SELL Open market or private sale	$1,007,725 $20.14 p/Share	50,036 Reduced 35.64%	90,365 Ordinary Shares
Dec 09 2025	BUY Exercise of conversion of derivative security	$802,380 $9.33 p/Share	86,000 Added 38.19%	139,218 Ordinary Shares
Dec 08 2025	SELL Open market or private sale	$3,118,500 $14.85 p/Share	210,000 Reduced 70.18%	89,218 Ordinary Shares
Dec 08 2025	BUY Exercise of conversion of derivative security	$749,700 $3.57 p/Share	210,000 Added 60.13%	139,218 Ordinary Shares
Feb 04 2025	BUY Grant, award, or other acquisition	-	42,000 Added 32.01%	89,218 Ordinary Shares
Oct 11 2024	BUY Exercise of conversion of derivative security	$62,000 $2.48 p/Share	25,000 Added 35.83%	44,777 Ordinary Shares
Sep 25 2024	SELL Open market or private sale	$154,314 $9.0 p/Share	17,146 Reduced 46.44%	19,777 Ordinary Shares

Apr 03 2024	SELL Open market or private sale	$96,437 $6.17 p/Share	15,630 Reduced 31.54%	33,921 Ordinary Shares
Aug 23 2023	SELL Open market or private sale	$176,044 $4.75 p/Share	37,062 Reduced 44.56%	46,120 Ordinary Shares
Feb 16 2023	SELL Open market or private sale	$39,305 $4.04 p/Share	9,729 Reduced 10.87%	79,751 Ordinary Shares
May 05 2022	SELL Open market or private sale	$8,636 $1.72 p/Share	5,021 Reduced 5.6%	84,567 Ordinary Shares
May 04 2022	BUY Grant, award, or other acquisition	-	15,000 Added 14.34%	89,588 Ordinary Shares
Feb 16 2022	SELL Open market or private sale	$21,261 $2.31 p/Share	9,204 Reduced 10.98%	74,588 Ordinary Shares
Mar 24 2021	BUY Exercise of conversion of derivative security	$27,106 $2.48 p/Share	10,930 Added 11.92%	80,792 Ordinary Shares
Feb 16 2021	SELL Open market or private sale	$18,202 $10.57 p/Share	1,722 Reduced 2.41%	69,862 Ordinary Shares
Feb 01 2021	BUY Grant, award, or other acquisition	-	50,000 Added 41.12%	71,584 Ordinary Shares

Kyle Moran

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WVE shares.

Notify only if

Value

Insider Trading

Get notified when an Wave Life Sciences Ltd. insider buys or sells WVE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Wave Life Sciences Ltd.

Track Activities on WVE

Account